Evidence map›Paper›PMID 37716914›Full record

ArticleFEBS open bio2023

UbiN, a novel Rhodobacter capsulatus decarboxylative hydroxylase involved in aerobic ubiquinone biosynthesis.

Haruka Nagatani, Yoshiyuki Mae, Miharu Konishi, Motomichi Matsuzaki, Kiyoshi Kita, Fevzi Daldal, Kimitoshi Sakamoto

Open access · goldAbstract read
In one paragraph

Article in FEBS open bio, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. A novel quinone biosynthetic pathway illuminates the evolution of aerobic metabolism.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 2 countries.

Haruka NagataniUnited Graduate School of Agricultural Sciences, Iwate University, Morioka, Japan.
Yoshiyuki MaeFaculty of Agriculture and Life Science, Hirosaki University, Japan.
Miharu KonishiFaculty of Agriculture and Life Science, Hirosaki University, Japan.
Motomichi MatsuzakiRIKEN Center for Advanced Intelligence Project, Tokyo, Japan.ORCID 0000-0001-5811-798X
Kiyoshi KitaSchool of Tropical Medicine and Global Health, Nagasaki University, Japan.
Fevzi DaldalDepartment of Biology, University of Pennsylvania, Philadelphia, PA, USA.
Kimitoshi SakamotoUnited Graduate School of Agricultural Sciences, Iwate University, Morioka, Japan.ORCID 0000-0003-4614-9428
Hirosaki University · JPIwate University · JPNagasaki University · JPRIKEN Center for Advanced Intelligence Project · JPUniversity of Pennsylvania · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ubiquinone (UQ) is a lipophilic electron carrier that functions in the respiratory and photosynthetic electron transfer chains of proteobacteria and eukaryotes. Bacterial UQ biosynthesis is well studied in the gammaproteobacterium Escherichia coli, in which most bacterial UQ-biosynthetic enzymes have been identified. However, these enzymes are not always conserved among UQ-containing bacteria. In particular, the alphaproteobacterial UQ biosynthesis pathways contain many uncharacterized steps with unknown features. In this work, we identified in the alphaproteobacterium Rhodobacter capsulatus a new decarboxylative hydroxylase and named it UbiN. Remarkably, the UbiN sequence is more similar to a salicylate hydroxylase than the conventional flavin-containing UQ-biosynthetic monooxygenases. Under aerobic conditions, R. capsulatus ΔubiN mutant cells accumulate 3-decaprenylphenol, which is a UQ-biosynthetic intermediate. In addition, 3-decaprenyl-4-hydroxybenzoic acid, which is the substrate of UQ-biosynthetic decarboxylase UbiD, also accumulates in ΔubiN cells under aerobic conditions. Considering that the R. capsulatus ΔubiD-X double mutant strain (UbiX produces a prenylated FMN required for UbiD) grows as a wild-type strain under aerobic conditions, these results indicate that UbiN catalyzes the aerobic decarboxylative hydroxylation of 3-decaprenyl-4-hydroxybenzoic acid. This is the first example of the involvement of decarboxylative hydroxylation in ubiquinone biosynthesis. This finding suggests that the C1 hydroxylation reaction is, at least in R. capsulatus, the first step among the three hydroxylation steps involved in UQ biosynthesis. Although the C5 hydroxylation reaction is often considered to be the first hydroxylation step in bacterial UQ biosynthesis, it appears that the R. capsulatus pathway is more similar to that found in mammalians.

Indexed as

Rhodobacter capsulatusAnimalsEscherichia coliHydroxybenzoatesMammalsMixed Function OxygenasesParabensUbiquinone3-hydroxybenzoic acid4-hydroxybenzoic acidHydroxybenzoatesMixed Function OxygenasesParabensUbiquinonecoenzyme Qdecarboxylative hydrolaseflavin monooxygenaseRhodobacter capsulatusubiquinone biosynthesis

Identifiers

PMID37716914
PMCPMC10626278
OpenAlexW4386797045

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.